Loading…
Cervical Cancer : Is Vaccination Necessary in India?
In India, cervical cancer is the most common woman-related cancer, followed by breast cancer. The rate of cervical cancer in India is fourth worldwide. Two vaccines, Gardasil and Cervarix, both targeting HPV-16 and 18 which account for 70% of invasive cervical carcinomas, are licensed in the United...
Saved in:
Published in: | Asian Pacific journal of cancer prevention : APJCP 2013, Vol.14 (4), p.2681-2684 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | Korean |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 2684 |
container_issue | 4 |
container_start_page | 2681 |
container_title | Asian Pacific journal of cancer prevention : APJCP |
container_volume | 14 |
creator | Farhath, Seema Vijaya, P.P Mumtaj, P |
description | In India, cervical cancer is the most common woman-related cancer, followed by breast cancer. The rate of cervical cancer in India is fourth worldwide. Two vaccines, Gardasil and Cervarix, both targeting HPV-16 and 18 which account for 70% of invasive cervical carcinomas, are licensed in the United States and numerous countries worldwide. Both vaccine formulations have shown excellent efficacy with minimal toxicity in active female population but numerous questions arise in vaccinating like cost effectiveness, lack of proven efficacy against other HPV strains, social acceptance of HPV vaccination and other ethical issues. The main objective of this study is to emphasis the advantages and disadvantages of the vaccination in India. |
format | article |
fullrecord | <record><control><sourceid>kisti</sourceid><recordid>TN_cdi_kisti_ndsl_JAKO201321251181332</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JAKO201321251181332</sourcerecordid><originalsourceid>FETCH-kisti_ndsl_JAKO2013212511813323</originalsourceid><addsrcrecordid>eNqNyr0KwjAQAOAgChbtO9ziWGh-mhQXkaJYhbqIuJUzjXBYIvSK4Nu7-ABO3_JNRKKMs5mz6jYViSykzpy25VykzHTPjXE6t8YkwlRheJPHHiqMPgywhprhit5TxJFeEZrgAzMOH6AIdewIN0sxe2DPIf25EKv97lIdsifxSG3suG-P29NZ5VIrqQopS6m10v--L79JM5c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cervical Cancer : Is Vaccination Necessary in India?</title><source>EZB Electronic Journals Library</source><creator>Farhath, Seema ; Vijaya, P.P ; Mumtaj, P</creator><creatorcontrib>Farhath, Seema ; Vijaya, P.P ; Mumtaj, P</creatorcontrib><description>In India, cervical cancer is the most common woman-related cancer, followed by breast cancer. The rate of cervical cancer in India is fourth worldwide. Two vaccines, Gardasil and Cervarix, both targeting HPV-16 and 18 which account for 70% of invasive cervical carcinomas, are licensed in the United States and numerous countries worldwide. Both vaccine formulations have shown excellent efficacy with minimal toxicity in active female population but numerous questions arise in vaccinating like cost effectiveness, lack of proven efficacy against other HPV strains, social acceptance of HPV vaccination and other ethical issues. The main objective of this study is to emphasis the advantages and disadvantages of the vaccination in India.</description><identifier>ISSN: 1513-7368</identifier><identifier>EISSN: 2476-762X</identifier><language>kor</language><ispartof>Asian Pacific journal of cancer prevention : APJCP, 2013, Vol.14 (4), p.2681-2684</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4022</link.rule.ids></links><search><creatorcontrib>Farhath, Seema</creatorcontrib><creatorcontrib>Vijaya, P.P</creatorcontrib><creatorcontrib>Mumtaj, P</creatorcontrib><title>Cervical Cancer : Is Vaccination Necessary in India?</title><title>Asian Pacific journal of cancer prevention : APJCP</title><addtitle>Asian Pacific journal of cancer prevention : APJCP</addtitle><description>In India, cervical cancer is the most common woman-related cancer, followed by breast cancer. The rate of cervical cancer in India is fourth worldwide. Two vaccines, Gardasil and Cervarix, both targeting HPV-16 and 18 which account for 70% of invasive cervical carcinomas, are licensed in the United States and numerous countries worldwide. Both vaccine formulations have shown excellent efficacy with minimal toxicity in active female population but numerous questions arise in vaccinating like cost effectiveness, lack of proven efficacy against other HPV strains, social acceptance of HPV vaccination and other ethical issues. The main objective of this study is to emphasis the advantages and disadvantages of the vaccination in India.</description><issn>1513-7368</issn><issn>2476-762X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNyr0KwjAQAOAgChbtO9ziWGh-mhQXkaJYhbqIuJUzjXBYIvSK4Nu7-ABO3_JNRKKMs5mz6jYViSykzpy25VykzHTPjXE6t8YkwlRheJPHHiqMPgywhprhit5TxJFeEZrgAzMOH6AIdewIN0sxe2DPIf25EKv97lIdsifxSG3suG-P29NZ5VIrqQopS6m10v--L79JM5c</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Farhath, Seema</creator><creator>Vijaya, P.P</creator><creator>Mumtaj, P</creator><scope>JDI</scope></search><sort><creationdate>2013</creationdate><title>Cervical Cancer : Is Vaccination Necessary in India?</title><author>Farhath, Seema ; Vijaya, P.P ; Mumtaj, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kisti_ndsl_JAKO2013212511813323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farhath, Seema</creatorcontrib><creatorcontrib>Vijaya, P.P</creatorcontrib><creatorcontrib>Mumtaj, P</creatorcontrib><collection>KoreaScience (Open Access)</collection><jtitle>Asian Pacific journal of cancer prevention : APJCP</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farhath, Seema</au><au>Vijaya, P.P</au><au>Mumtaj, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cervical Cancer : Is Vaccination Necessary in India?</atitle><jtitle>Asian Pacific journal of cancer prevention : APJCP</jtitle><addtitle>Asian Pacific journal of cancer prevention : APJCP</addtitle><date>2013</date><risdate>2013</risdate><volume>14</volume><issue>4</issue><spage>2681</spage><epage>2684</epage><pages>2681-2684</pages><issn>1513-7368</issn><eissn>2476-762X</eissn><abstract>In India, cervical cancer is the most common woman-related cancer, followed by breast cancer. The rate of cervical cancer in India is fourth worldwide. Two vaccines, Gardasil and Cervarix, both targeting HPV-16 and 18 which account for 70% of invasive cervical carcinomas, are licensed in the United States and numerous countries worldwide. Both vaccine formulations have shown excellent efficacy with minimal toxicity in active female population but numerous questions arise in vaccinating like cost effectiveness, lack of proven efficacy against other HPV strains, social acceptance of HPV vaccination and other ethical issues. The main objective of this study is to emphasis the advantages and disadvantages of the vaccination in India.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1513-7368 |
ispartof | Asian Pacific journal of cancer prevention : APJCP, 2013, Vol.14 (4), p.2681-2684 |
issn | 1513-7368 2476-762X |
language | kor |
recordid | cdi_kisti_ndsl_JAKO201321251181332 |
source | EZB Electronic Journals Library |
title | Cervical Cancer : Is Vaccination Necessary in India? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T22%3A56%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kisti&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cervical%20Cancer%20:%20Is%20Vaccination%20Necessary%20in%20India?&rft.jtitle=Asian%20Pacific%20journal%20of%20cancer%20prevention%20:%20APJCP&rft.au=Farhath,%20Seema&rft.date=2013&rft.volume=14&rft.issue=4&rft.spage=2681&rft.epage=2684&rft.pages=2681-2684&rft.issn=1513-7368&rft.eissn=2476-762X&rft_id=info:doi/&rft_dat=%3Ckisti%3EJAKO201321251181332%3C/kisti%3E%3Cgrp_id%3Ecdi_FETCH-kisti_ndsl_JAKO2013212511813323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |